• Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 01 Nov 2024 04:02:14   America/Chicago


    Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Amicus Therapeutics, Inc.
    Read more...
Share on,